Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS) is a chronic skin condition characterized by painful lumps, abscesses, and scarring, typically occurring in areas where skin rubs together, such as the armpits and groin.
Hidradenitis Suppurativa: Lutikizumab Study
We are evaluating the effectiveness and safety of lutikizumab for treating moderate to severe hidradenitis suppurativa in adults and adolescents. This study compares lutikizumab to a placebo to see how well it works.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 12 years old?
- Do you have moderate to severe hidradenitis suppurativa (HS) that has lasted for at least 6 months?
- Have you had at least 5 abscesses or nodules related to HS?
- Have you had an inadequate response to a 12-week course of oral antibiotics for HS?
- Do you have HS lesions in at least two different areas of your body?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Lutikizumab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Universitaetsklinik fuer Dermatologie und Venerologie
Graz, Austria
Medical University Of Vienna
Universitaetsklinik fuer Dermatologie
Vienna, Austria
Grand Hopital De Charleroi
Dermatology
Charleroi, Belgium
Sponsor: AbbVie Deutschland GmbH & Co. KG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.